Targeted carrier fusions for delivery of chemotherapeutic agents
    3.
    发明申请
    Targeted carrier fusions for delivery of chemotherapeutic agents 有权
    靶向载体融合用于递送化学治疗剂

    公开(公告)号:US20050059122A1

    公开(公告)日:2005-03-17

    申请号:US10912764

    申请日:2004-08-05

    申请人: Ben Shen

    发明人: Ben Shen

    摘要: The present invention provides for fusion proteins that act as targeted drug carries. The proteins are derived from molecules that possess natural drug-binding capabilities that are further engineered to target specific cell types, and optionally to have altered/improved drug binding characteristics. These fusion proteins are useful in, for example, delivery of chemotherapeutic compounds to cancer cells.

    摘要翻译: 本发明提供用作靶向药物载体的融合蛋白。 蛋白质衍生自具有天然药物结合能力的分子,其进一步工程化以靶向特定细胞类型,并且任选具有改变/改善的药物结合特征。 这些融合蛋白可用于例如将化疗化合物递送至癌细胞。

    GLUTARIMIDE-CONTAINING POLYKETIDE ANALOGS AND METHODS THEREOF
    4.
    发明申请
    GLUTARIMIDE-CONTAINING POLYKETIDE ANALOGS AND METHODS THEREOF 审中-公开
    含谷氨酰胺的聚合物模拟物及其方法

    公开(公告)号:US20060211736A1

    公开(公告)日:2006-09-21

    申请号:US11275556

    申请日:2006-01-13

    申请人: Ben Shen

    发明人: Ben Shen

    摘要: The present invention provides library of glutarimide-containing polyketide analogs, such as analogs of migrastatin, iso-migrastatin, dorrigocin A and B, epi-dorrigocin, NK30424 A and B and lactimidomycin, methods of synthesizing and using these analogs and further methods of creating a combinatorial library of these compounds through chemical modifications.

    摘要翻译: 本发明提供了含有戊二酰亚胺的聚酮化合物类似物的文库,例如migrastatin,异伐米他汀,dorrigocin A和B,epi-dorrigocin,NK30424A和B以及类似物的类似物,合成和使用这些类似物的方法以及进一步的创造方法 这些化合物的组合文库通过化学修饰。

    Electro-chemical deposition system and method
    6.
    发明授权
    Electro-chemical deposition system and method 失效
    电化学沉积系统及方法

    公开(公告)号:US06254760B1

    公开(公告)日:2001-07-03

    申请号:US09263649

    申请日:1999-03-05

    IPC分类号: G01F164

    摘要: The present invention generally provides an electro-chemical deposition system that is designed with a flexible architecture that is expandable to accommodate future designs rules and gap fill requirements and provides satisfactory throughput to meet the demands of other processing systems. The electro-chemical deposition system generally comprises a front-end loading station, a mainframe including one or more processing cells, and an electrolyte replenishing system fluidly connected to the one or more electrical processing cells. The electrolyte replenishing system comprises a main electrolyte supply tank and an analyzer module and dosing module coupled thereto. The analyzer module includes one or more chemical analyzers to monitor the concentrations of various chemicals in the main electrolyte supply tank. Information provided by the analyzer module is transmitted via a central control system to the dosing module. Source tanks in the dosing module communicate with the main supply tank to deliver the desired proportions of chemicals thereto. Preferably, the electrolyte analysis is performed continuously during processing to provide real-time data and electrolyte adjustments.

    摘要翻译: 本发明通常提供一种电化学沉积系统,其被设计成具有可扩展以适应未来设计规则和间隙填充要求的柔性结构,并提供令人满意的吞吐量以满足其它处理系统的需求。 电化学沉积系统通常包括前端加载站,包括一个或多个处理单元的主框架和与该一个或多个电处理单元流体连接的电解质补充系统。 电解质补充系统包括主要电解质供应罐和与其耦合的分析器模块和计量模块。 分析仪模块包括一个或多个化学分析仪,用于监测主要电解质供应罐中各种化学物质的浓度。 由分析器模块提供的信息经由中央控制系统传送到计量模块。 计量模块中的来源罐与主供应罐连通,以将所需比例的化学品运送到其上。 优选地,在处理期间连续执行电解质分析以提供实时数据和电解质调节。

    Platensimycin biosynthetic gene cluster of Streptomyces platensis
    7.
    发明授权
    Platensimycin biosynthetic gene cluster of Streptomyces platensis 有权
    链霉菌的Platensimycin生物合成基因簇

    公开(公告)号:US08652838B2

    公开(公告)日:2014-02-18

    申请号:US12179406

    申请日:2008-07-24

    IPC分类号: C12N15/00 C12N1/20

    摘要: The present invention relates to the cloning and sequence of a biosynthetic gene cluster from Streptomyces platensis that produces platensimycin and platencin. Also provided are engineered micro-organisms for the production of these compounds, and analogs thereto, as well as methods of screening for compounds with anti-bacterial activity.

    摘要翻译: 本发明涉及产生拉米霉素和平板菌素的来自Plreptomyces platensis的生物合成基因簇的克隆和序列。 还提供了用于生产这些化合物的工程微生物及其类似物,以及筛选具有抗细菌活性的化合物的方法。

    Tautomycetin and tautomycetin analog biosynthesis
    8.
    发明授权
    Tautomycetin and tautomycetin analog biosynthesis 有权
    Tautomycetin和tautomycetin类似物生物合成

    公开(公告)号:US08580977B2

    公开(公告)日:2013-11-12

    申请号:US13101624

    申请日:2011-05-05

    申请人: Ben Shen

    发明人: Ben Shen

    IPC分类号: C07D303/00 C12P17/04

    CPC分类号: C12P17/04 C07D307/58

    摘要: The present invention relates to the biosynthetic gene cluster for tautomycetin (TTN) produces tautomycetin. Also provided are engineered micro-organisms for the production of TTN and analogs thereof, as well as methods of screening for compounds for activity.

    摘要翻译: 本发明涉及抗菌素(TTN)的生物合成基因簇产生抗菌素。 还提供了用于生产TTN及其类似物的工程微生物以及筛选用于活性的化合物的方法。